Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells

Yumei Wu, Mikiro Tada, Kyoya Takahata, Kazuhito Tomizawa, Hideki Matsui

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Neuronal apoptosis is involved in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. An efficient means of preventing it remains to be found. Some n-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic acid (EPA, 20:5n-3) have been reported to be protective against the neuronal apoptosis and neuronal degeneration seen after spinal cord injury (SCI) [1]. However, it is unclear which kinds of PUFAs have the most potent ability to inhibit neuronal apoptosis and whether the simultaneous treatment of PUFAs inhibits the apoptosis. In the present study, we compared the abilities of various n-3- and n-6-PUFAs to inhibit the apoptosis induced after the administration of different apoptotic inducers, etoposide, okadaic acid, and AraC, in mouse neuroblastoma cells (Neuro2a). Preincubation with DHA (22:6n-3), eicosapentaenoic acid (EPA, 20:5n-3), α-linolenic acid (α-LNA, 18:3n-3), linoleic acid (LA, 18:2n-6), arachidonic acid (AA, 20:4n-3), and γ-linolenic acid (γ-LNA, 18:3n-6) significantly inhibited caspase-3 activity and LDH leakage but simultaneous treatment with the PUFAs had no effect on the apoptosis of Neuro2a cells. There were no significant differences of the anti-apoptotic effect among the PUFAs. These results suggest that PUFAs may not be effective for inhibiting neuronal cell death after acute and chronic neurodegenerative disorders. However, dietary supplementation with PUFAs may be beneficial as a potential means to delay the onset of the diseases and/or their rate of progression. Copyright

Original languageEnglish
Pages (from-to)147-152
Number of pages6
JournalActa Medica Okayama
Volume61
Issue number3
Publication statusPublished - Jun 2007

Fingerprint

Okadaic Acid
Etoposide
Unsaturated Fatty Acids
Apoptosis
Aptitude
alpha-Linolenic Acid
Eicosapentaenoic Acid
Neurodegenerative Diseases
Neurodegenerative diseases
Docosahexaenoic Acids
Omega-3 Fatty Acids
Cell death
Linoleic Acid
Dietary Supplements
Neuroblastoma
Spinal Cord Injuries
Arachidonic Acid
Caspase 3
Parkinson Disease
Alzheimer Disease

Keywords

  • Caspase
  • DHA
  • Neurodegenerative disease
  • Neuronal apoptosis
  • Polyunsaturated fatty acid (PUFA)

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells. / Wu, Yumei; Tada, Mikiro; Takahata, Kyoya; Tomizawa, Kazuhito; Matsui, Hideki.

In: Acta Medica Okayama, Vol. 61, No. 3, 06.2007, p. 147-152.

Research output: Contribution to journalArticle

Wu, Yumei ; Tada, Mikiro ; Takahata, Kyoya ; Tomizawa, Kazuhito ; Matsui, Hideki. / Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells. In: Acta Medica Okayama. 2007 ; Vol. 61, No. 3. pp. 147-152.
@article{4f8f4a68e50d41d69e9efa08b0cb132c,
title = "Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells",
abstract = "Neuronal apoptosis is involved in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. An efficient means of preventing it remains to be found. Some n-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic acid (EPA, 20:5n-3) have been reported to be protective against the neuronal apoptosis and neuronal degeneration seen after spinal cord injury (SCI) [1]. However, it is unclear which kinds of PUFAs have the most potent ability to inhibit neuronal apoptosis and whether the simultaneous treatment of PUFAs inhibits the apoptosis. In the present study, we compared the abilities of various n-3- and n-6-PUFAs to inhibit the apoptosis induced after the administration of different apoptotic inducers, etoposide, okadaic acid, and AraC, in mouse neuroblastoma cells (Neuro2a). Preincubation with DHA (22:6n-3), eicosapentaenoic acid (EPA, 20:5n-3), α-linolenic acid (α-LNA, 18:3n-3), linoleic acid (LA, 18:2n-6), arachidonic acid (AA, 20:4n-3), and γ-linolenic acid (γ-LNA, 18:3n-6) significantly inhibited caspase-3 activity and LDH leakage but simultaneous treatment with the PUFAs had no effect on the apoptosis of Neuro2a cells. There were no significant differences of the anti-apoptotic effect among the PUFAs. These results suggest that PUFAs may not be effective for inhibiting neuronal cell death after acute and chronic neurodegenerative disorders. However, dietary supplementation with PUFAs may be beneficial as a potential means to delay the onset of the diseases and/or their rate of progression. Copyright",
keywords = "Caspase, DHA, Neurodegenerative disease, Neuronal apoptosis, Polyunsaturated fatty acid (PUFA)",
author = "Yumei Wu and Mikiro Tada and Kyoya Takahata and Kazuhito Tomizawa and Hideki Matsui",
year = "2007",
month = "6",
language = "English",
volume = "61",
pages = "147--152",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "3",

}

TY - JOUR

T1 - Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells

AU - Wu, Yumei

AU - Tada, Mikiro

AU - Takahata, Kyoya

AU - Tomizawa, Kazuhito

AU - Matsui, Hideki

PY - 2007/6

Y1 - 2007/6

N2 - Neuronal apoptosis is involved in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. An efficient means of preventing it remains to be found. Some n-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic acid (EPA, 20:5n-3) have been reported to be protective against the neuronal apoptosis and neuronal degeneration seen after spinal cord injury (SCI) [1]. However, it is unclear which kinds of PUFAs have the most potent ability to inhibit neuronal apoptosis and whether the simultaneous treatment of PUFAs inhibits the apoptosis. In the present study, we compared the abilities of various n-3- and n-6-PUFAs to inhibit the apoptosis induced after the administration of different apoptotic inducers, etoposide, okadaic acid, and AraC, in mouse neuroblastoma cells (Neuro2a). Preincubation with DHA (22:6n-3), eicosapentaenoic acid (EPA, 20:5n-3), α-linolenic acid (α-LNA, 18:3n-3), linoleic acid (LA, 18:2n-6), arachidonic acid (AA, 20:4n-3), and γ-linolenic acid (γ-LNA, 18:3n-6) significantly inhibited caspase-3 activity and LDH leakage but simultaneous treatment with the PUFAs had no effect on the apoptosis of Neuro2a cells. There were no significant differences of the anti-apoptotic effect among the PUFAs. These results suggest that PUFAs may not be effective for inhibiting neuronal cell death after acute and chronic neurodegenerative disorders. However, dietary supplementation with PUFAs may be beneficial as a potential means to delay the onset of the diseases and/or their rate of progression. Copyright

AB - Neuronal apoptosis is involved in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. An efficient means of preventing it remains to be found. Some n-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic acid (EPA, 20:5n-3) have been reported to be protective against the neuronal apoptosis and neuronal degeneration seen after spinal cord injury (SCI) [1]. However, it is unclear which kinds of PUFAs have the most potent ability to inhibit neuronal apoptosis and whether the simultaneous treatment of PUFAs inhibits the apoptosis. In the present study, we compared the abilities of various n-3- and n-6-PUFAs to inhibit the apoptosis induced after the administration of different apoptotic inducers, etoposide, okadaic acid, and AraC, in mouse neuroblastoma cells (Neuro2a). Preincubation with DHA (22:6n-3), eicosapentaenoic acid (EPA, 20:5n-3), α-linolenic acid (α-LNA, 18:3n-3), linoleic acid (LA, 18:2n-6), arachidonic acid (AA, 20:4n-3), and γ-linolenic acid (γ-LNA, 18:3n-6) significantly inhibited caspase-3 activity and LDH leakage but simultaneous treatment with the PUFAs had no effect on the apoptosis of Neuro2a cells. There were no significant differences of the anti-apoptotic effect among the PUFAs. These results suggest that PUFAs may not be effective for inhibiting neuronal cell death after acute and chronic neurodegenerative disorders. However, dietary supplementation with PUFAs may be beneficial as a potential means to delay the onset of the diseases and/or their rate of progression. Copyright

KW - Caspase

KW - DHA

KW - Neurodegenerative disease

KW - Neuronal apoptosis

KW - Polyunsaturated fatty acid (PUFA)

UR - http://www.scopus.com/inward/record.url?scp=34447306891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447306891&partnerID=8YFLogxK

M3 - Article

C2 - 17593950

AN - SCOPUS:34447306891

VL - 61

SP - 147

EP - 152

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 3

ER -